CM
TECH icon

Caption Management’s Bio-Techne TECH Stock Holding History

Caption Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.5M Sell
200,000
-202,200
-50% -$12.1M 0.06% 322
2025
Q4 		$23.7M Buy
402,200
+284,700
+242% +$17.3M 0.16% 147
2025
Q3 		$6.54M Buy
+117,500
New +$6.29M 0.05% 396
2024
Q4 		– Sell
-15,000
Closed -$1.2M – 1821
2024
Q3 		$1.2M Buy
+15,000
New +$1.13M 0.02% 725

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caption Management's TECH Position: Q1 2026 in Review

Caption Management sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 100,000 shares — an estimated $6M sold.

Caption Management first reported a position in TECH in Q3 2025 and held it in 2 quarters. The position peaked at $5.88M in Q4 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Caption Management reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 100,000 Bio-Techne shares in Q1 2026, an estimated $6M.
  • Caption Management first reported a position in Bio-Techne in Q3 2025 and held it in 2 quarters.
  • Caption Management's Bio-Techne position peaked at $5.88M in Q4 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.